Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences Unit-1 Completed GMP Inspection From Anvisa
04/07/2025 15:27
July 4 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA MEDICARE LTD - SHILPA PHARMA LIFESCIENCES UNIT-1 COMPLETED GMP INSPECTION FROM ANVISA Source text: ID:nBSE6zdmZD Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026